Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity

Abstract

We investigated whether premature telomeric loss occurred in peripheral polymorphonuclear neutrophils (PMN) as well as mononuclear cells (MNC) from patients with systemic lupus erythematosus (SLE). We measured the telomere length of MNC and PMN in 60 SLE patients and 26 sex-, race- and age-matched healthy volunteers by Southern blotting with chemiluminescence method. The possible predisposing factors associated with telomere change were also analysed. We found the telomere length of MNC and PMN shortened with age in different degrees in both SLE and control groups. Compared to the control group, the telomere length was shortened in both SLE-MNC (6.08 kb in SLE versus 6.71 kb in control, P = 0.0008) and PMN (6.24 kb in SLE versus 6.75 kb in control, P = 0.0025). The average reduction in telomere length in SLE patients was equivalent to a premature senescence of 16.5 years in MNC and 13.4 years in PMN. In addition, the accelerated telomere shortening was more prominent in SLE patients younger than 45 years old. SLE disease activity (SLEDAI) contributed remarkably to the accelerated telomere erosion, at least in PMN. Moreover, the telomere length of MNC was significantly shorter than PMN in the same SLE patients with leukopenia and lymphopenia. These data suggested that MNC and PMN from patients with SLE displayed premature and accelerated telomere shortening that SLE is an independent factor for it. Lupus (2007) 16, 265—272.

Keywords

mononuclear cells polymorphonuclear neutrophils premature telomere shortening systemic lupus erythematosus telomere length

Get full access to this article

View all access options for this article.

References

Zakian VA Telomeres: beginning to understand the end. Science 1995; 270: 1601—1607.

Blackburn EH Structure and function of telomeres. Nature 1991; 350: 569—573.

Kipling D. Telomeres, replicative senescence and human ageing. Maturitas 2001; 38: 25—38.

Klapper W. , Parwaresch R. , Krupp G. Telomere biology in human aging and aging syndromes. Mech Ageing Dev 2001; 122: 695—712.

Kim NW , Piatyszek MA , Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011—2015.

Tarazona R. , Solana R. , Ouyang Q. , Pawelec G. Basic biology and clinical impact of immunosenescence. Exp Gerontol 2002; 37: 183—189.

Rus V. , Via CS Telomeres, telomerase, and lupus: the long and short of it. Clin Immunol 2001; 99: 195—197.

Honda M. , Mengesha E. , Albano S. et al. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8 + CD28(lo) T cells in patients with systemic lupus erythematosus. Clin Immunol 2001; 99: 211—221.

Katayama Y. , Kohriyama K. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol 2001 ; 28: 288—291.

10.

Kurosaka D. , Ozawa Y. , Yasuda J. et al. Telomerase activity in peripheral blood mononuclear cells from patients with SLE. Ann Rheum Dis 2001; 60: 1158—1159.

11.

Kurosaka D. , Yasuda J. , Yoshida K. et al. Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients . Lupus 2003; 12: 591—599.

12.

Klapper W. , Moosig F. , Sotnikova A. , Qian W. , Schroder JO , Parwaresch R. Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1681—1683.

13.

Kurosaka D. , Yasuda J. , Yoshida K. et al. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 1102—1107.

14.

Schonland SO , Lopez C. , Widmann T. et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003 ; 100: 13471—13476.

15.

Koetz K. , Bryl E. , Spickschen K. , O'Fallon WM , Goronzy JJ , Weyand CM T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000; 97: 9203—9208.

16.

Wagner UG , Koetz K. , Weyand CM , Goronzy JJ Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 1998; 5: 14447—14452.

17.

Artlett CM , Black CM , Briggs DC , Stevens CO , Welsh KI Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol 1996; 35: 732—737.

18.

Wu K. , Higashi N. , Hansen ER , Lund M. , Bang K. , Thestrup-Pedersen K. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 2000; 165: 4742—4747.

19.

Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

20.

Grossman JM , Kalunian KC Definition, classfication, activity, and damage indices. In Wallace DJ , Hahn BH eds. Dubois' lupus erythematosus, 6th edition. Lippincott Willians & Wilkins, 2002: 19—31.

21.

Hodes RJ Telomere length, aging, and somatic cell turnover. J Exp Med 1999; 190: 153—156.

22.

Allsopp RC , Vaziri H. , Patterson C. et al. Telomere length predicts replicative capacity of human fibroblasts . Proc Natl Acad Sci USA 1992; 89: 10114—10118.

23.

Weng NP Interplay between telomere length and telomerase in human leukocyte differentiation and aging. J Leukoc Biol 2001 ; 70: 861—867.

24.

Widmann TA , Willmann B. , Pfreundschuh M. , Beelen DW Influence of telomere length on short-term recovery after allogeneic stem cell transplantation. Exp Hematol 2005 ; 33: 1257—1261.

25.

Courtney PA , Crockard AD , Williamson K. , Irvine AE , Kennedy RJ , Bell AL Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58: 309—314.

26.

Courtney PA , Crockard AD , Williamson K. , McConnell J. , Kennedy RJ , Bell AL Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity . Lupus 1999 ; 8: 508—513.

27.

von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 2000; 908: 99—110.

28.

von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339—344.

29.

Serra V. , von Zglinicki T. , Lorenz M. , Saretzki G. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 2003; 278: 6824—6830.

30.

Alves JD , Grima B. Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis. Curr Rheumatol Rep 2003; 5: 383—390.

31.

Bashir S. , Harris G. , Denman MA , Blake DR , Winyard PG Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993; 52: 659—666.

32.

Slagboom PE , Droog S. , Boomsma DI Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994; 55: 876—882.

33.

Tsirpanlis G. , Chatzipanagiotou S. , Boufidou F. et al. Telomerase activity is decreased in peripheral blood mononuclear cells of hemodialysis patients. Am J Nephrol 2006; 26: 91—96.

34.

Ramirez R. , Carracedo J. , Soriano S. , Jimenez R. , Martin-Malo A. , Rodriguez M. et al. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am J Kidney Dis 2005; 45: 353—359.

35.

Boxall MC , Goodship TH , Brown AL , Ward MC , von Zglinicki T. Telomere shortening and haemodialysis. Blood Purif 2006; 24: 185—189.

36.

Wallace DJ , Salonen EM , Avaniss-Aghajani E. , Morris R. , Metzger AL , Pashinian N. Anti-telomere antibodies in systemic lupus erythematosus: a new ELISA test for anti-DNA with potential pathogenetic implications. Lupus 2000; 9: 328—332.

37.

Salonen EM , Miettinen A. , Walle TK , Koskenmies S. , Kere J. , Julkunen H. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Ann Rheum Dis 2004; 63: 1250—1254.

38.

Bryan TM , Reddel RR Telomere dynamics and telomerase activity in in vitro immortalized human cells . Eur J Cancer 1997; 33: 767—773.

39.

Biessmann H. , Mason JM Telomere maintenance without telomerase . Chromosoma 1997; 106: 63—69.

40.

Greider CW Telomere length regulation. Annu Rev Biochem 1996; 65: 337—365.